Impact of coronary artery tortuosity in ischemic and non-ischemic cardiovascular pathology

Dumitru Emilian Mihai1,2, Ioana Lupasteanu1, Gheorghe Andrei Dan3,1,2

  • 1Cardiology Department, Colentina Clinical Hospital, Bucharest, Romania.

Insights

Coronary artery tortuosity, a condition where arteries curve abnormally, can cause ischemia in non-obstructive coronary artery disease. This review explores its link to hypertension, heart function, and interventional challenges.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Coronary artery tortuosity is increasingly recognized as a significant factor in cardiovascular pathology.
  • Existing literature suggests a potential link between arterial tortuosity and ischemic events, particularly in non-obstructive coronary artery disease (CAD).
  • Hypertension is frequently associated with a higher prevalence of coronary tortuosity, necessitating further investigation into the underlying physio-pathological mechanisms.

Observation:

  • This review synthesizes current research on the physio-pathological implications of coronary artery tortuosity.
  • The study examines the role of tortuosity in inducing myocardial ischemia, especially in patients without obstructive coronary lesions.
  • Particular attention is given to the association between severe hypertension, hypertrophic heart conditions, and increased coronary tortuosity, exploring fluid dynamics and physiological changes.

Findings:

  • Coronary artery tortuosity can act as an independent physio-pathological mechanism contributing to ischemia in non-obstructive CAD.
  • The physio-pathological processes and altered fluid dynamics in hypertrophic hearts, exacerbated by severe hypertension, are linked to a higher prevalence of coronary tortuosity.
  • Coronary tortuosity negatively impacts systolic function, specifically longitudinal function and ventricular relaxation, and presents significant technical challenges during percutaneous coronary interventions.

Implications:

  • Understanding the role of coronary tortuosity is crucial for diagnosing and managing ischemia in patients with non-obstructive CAD.
  • Further research into the interplay between hypertension, cardiac structure, and coronary tortuosity may reveal novel therapeutic targets.
  • Addressing the technical complexities associated with tortuous coronary arteries is essential for improving outcomes in interventional cardiology.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
185
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.3K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
663
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
149
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
363
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
133